Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Polytheragene


Pépinière Genopole Entreprises – 4, rue Pierre Fontaine
91058 EVRY Cedex – France
Phone: +33 1 69 47 77 25
Email: herve.cheradame@univ-evry.fr

Hervé CHERADAME: President & CEO
Site Web >
Polytheragene - Genopole's Company Polytheragene - Genopole's Company

#R&D Services and Products

  • Transfection
  • Gene therapy
  • Biomanufacturing
  • Therapeutic proteins
  • Vaccine

Field of Activity


Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing.
Cosmetic and therapeutic molecules from plant biomass.

BACKGROUND
The association of two complementary teams from the MPI/LAMBE laboratories at the University of Évry and the molecular biophysics laboratory at Orléans led to the development of two patented polymer families for nucleic acid transfection.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Two families of synthetic agents have been developed. The first is derived from polyethylenimine and the second is formed by amphiphilic triblock copolymers for in vitro and in vivo applications. These compounds offer better efficacy and lower toxicity than market references.
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
New formulas are currently under development at the MPI lab (UEVE).
Common research with biomanufacturers showed the high performances (high efficacy, low toxicity) of these vectors for biomanufacturing in large volumes (higher than 50L) (GMP quality available).
COLLABORATIONS SOUGHT
We are looking for partnerships and co-development opportunities with biomanufacturers, companies offering high throughput cell screening and biotechnology laboratories developing DNA or RNA vaccines. Companies interested in new molecules of therapeutic or cosmetic interest from plant biomass.

  • Further Information

    Annual turnover: Greater than €100,000
    1 exclusive license from the university of Évry
    2 staff members
    Strengths:
    high performance synthetic vectors.
    Complementary teams in chemistry and biochemistry.
    Innovation assets:
    ability to develop high efficacy transfecting agents for specific applications (stem cells and cell suspension cultures).
    Other facts:
    new formulations for RNA transfer.

Share
Genopole’s Companies

#R&D Services and Products


In same field

Quibiotic - Projet Shaker

Quibiotic

Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.

Discover
Adlin Science - Genopole's Company

Adlin Science

ADLIN Science accompanies researchers in the management, analysis and valorization of multiomic data

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yubsis - Genopole's company

Yubsis

Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations (Pharma, Biotech, academic lab) willing to improve real-time teamwork, optimize performance and accelerate innovation.

Discover
Xentech - Genopole Company

XenTech

XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.

Discover
Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Phinc Development - Genopole's Company

PhinC Development

PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.

Discover
New England Biolabs - Genopole's Company

New England Biolabs France

New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.

Discover
LPS Biosciences - Genopole's company

LPS-BioSciences

LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.

Discover
Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

Discover
logo abcell Bio - Genopole's Companie

ABCell-Bio

Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

Discover
View all >
With the support from